Add-onHealthcare
Iron Path-backed VION Biosciences completes acquisition of Prolytix
Prolytix provides regulated bioanalytical and CMC services, research reagents and custom sample collection products to biopharma and diagnostics customers.
- Target
- Prolytix
- Backed by
- Iron Path Capital
- Source
- PEI Private Equity